The Analgesic Efficacy of Pericapsular Nerve Group Block in Patients with Intertrochanteric Femur Fracture

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055601

Enrollment

Unknown

Registered

2022-01-14

Start date

2020-10-29

Completion date

Unknown

Last updated

2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

PENGB group:Pericapsular nerve group block

FICB group:fascia iliaca compartment block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with femoral intertrochanteric fracture undergoing PFNA under general anesthesia in our hospital; 2. Aged 65 to 85 years; 3. American Society of anesthesiologists grade I-III; 4. Preoperative visual analog pain score = 4.

Exclusion criteria

Exclusion criteria: 1. Can't communicate in language; 2. Body mass index (BMI) > 30 kg/m2; 3. Known drug allergy; 4. Liver and kidney dysfunction; 5. Opioid addiction or dependence; 6. Cognitive impairment; 7. Recognized neuromuscular diseases; 8. Nerve block and local infection; 9. Operation time > 2 hours.

Design outcomes

Primary

Measure	Time frame
Visual analogue score;	—

Secondary

Measure	Time frame
Quadriceps femoris motor block;Opioid consumption;Analgesic satisfaction;Nerve block related complications;	—

Countries

China

Contacts

Public ContactMingjian Kong

The Second Affiliated Hospital of Xuzhou Medical University

MJKong@126.com+86 17751991669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026